| 卢玉朱,陈求凝,张雪梅.肺表面活性物质联合双水平气道正压通气对早产儿呼吸窘迫综合征肺功能及安全性影响[J].安徽医药,2022,26(2):338-342. |
| 肺表面活性物质联合双水平气道正压通气对早产儿呼吸窘迫综合征肺功能及安全性影响 |
| Effects of pulmonary surfactant and bilevel positive airway pressure on lung function and safety of RDS in preterm infants |
| |
| DOI：10.3969/j.issn.1009-6469.2022.02.031 |
| 中文关键词: 呼吸窘迫综合征，新生儿 婴儿，早产 肺表面活性物质 双水平气道正压通气 氧合功能 |
| 英文关键词: Respiratory distress syndrome,newborn Infant,premature Pulmonary surfactant Bilevel positive airway pressure ventilation Oxygenation function |
| 基金项目: |
|
| 摘要点击次数: 1172 |
| 全文下载次数: 530 |
| 中文摘要: |
| 目的分析肺表面活性物质( PS)联合双水平气道正压通气( BiPAP)对早产儿呼吸窘迫综合征( RDS)肺功能、氧合功能、血清指标及安全性影响。方法选取 2017年 1月至 2019年 1月三亚中心医院治疗的 RDS早产儿 120例，采用随机数字表法分为对照组和观察组，各 60例。对照组采用 PS联合持续气道正压通气( CPAP)治疗，观察组采用 PS联合 BiPAP治疗。观察两组肺功能、动脉血气指标、氧交换指标、血清因子与并发症情况。结果观察组每分通气量［( 0.53±0.04)L·min-1·kg-1 |
| 英文摘要: |
| Objective To analyze the effects of pulmonary surfactant and bilevel positive airway pressure (BiPAP) on lung function,oxygenation function, serum index and safety of preterm infants with respiratory distress syndrome (RDS).Methods One hundred and twenty cases of premature infants with RDS who were treated in Sanya Central Hospital from January 2017 to January 2019 were ran.domly assigned into control group and observation group, each group with 60 cases. Control group was treated with pulmonary surfac.tant (PS) combined with BiPAP combined with continuous positive airway pressure (CPAP), while the observation group was treatedwith PS combined with BiPAP. The pulmonary function, arterial blood gas indexes, oxygen exchange indexes, serum factors and compli.cations were observed in the two groups.Results The minute ventilation [(0.53±0.04) L·min-1·kg-1 vs. (0.44±0.05) L·min-1·kg-1] and tidal volume [(6.49±1.30) mL/kg vs. (5.48±1.15) mL/kg] of the observation group were higher than those of the control group, and the re.spiratory rate was lower than that of the control group [(42.51±3.94) times/min vs. (49.32±4.02) times/min] (P<0.05). There was no sig.nificant difference in TEF25%, TEF50%, TEF75%, peak time ratio, peak expiratory flow rate (PEF) and peak volume ratio (P>0.05); the pH value, arterial partial pressure of oxygen (PaO2), PaO2/PAO2, PaO2/FiO2 of the observation group at 6 h and 12 h after treatmentwere higher than those before treatment and the control group, and the arterial partial pressure of carbon dioxide (PaCO2) was lower than before treatment and the control group (P<0.05). Serum high mobility group protein 1 (HMGB-1), macrophage migration inhibitory factor-1 (MIF-1) and type II alveolar cell surface antigen (KL-6) levels of the observation group after 3 days of treatment were lower than those of before treatment and the control group (P<0.05). The hospitalization and oxygen therapy time of children of the observa. tion group was lower than that of the control group (P<0.05), there was no significant difference in complications between the two groups (P>0.05).Conclusion Pulmonary surfactant combined with BiPAP can effectively improve the oxygenation function and lungfunction in children with RDS, and it is safe in clinical application. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
